Pilot Study of Genesis® Neurostimulation System in Angina

Advanced Neuromodulation Systems, a division of St. Jude Medical, is reporting initiation of the US trial of its Genesis® Neurostimulation System. The trial will study the effectiveness of the system to alleviate symptoms of treatment-resistant angina. The company’s spinal cord stimulator was just implanted into a 53-year-old Massachusetts woman at Beth Israel Deaconess Medical Center in Boston, Mass. The device is thought to help patients, described as otherwise untreatable, that are suffering from disabling angina because they are not candidates for revascularization procedures such as bypass surgery or cardiac arterial stenting.
To learn more about the trial…
Press release…